PEPTIDE RESEARCH SERIES 03
Retatrutide
Tri-Agonist Peptide | GLP-1 / GIP / Glucagon
Price range: $159.00 through $289.00
In Stock
Third-Party Tested
COA Included
Research Grade
PEPTIDE INFORMATION
| Name | Retatrutide |
|---|---|
| Classification | Synthetic Tri-Agonist Peptide |
| Length | N/A |
| Origin | Synthetic |
| Research Areas | GLP-1 Receptor, GIP Receptor, Glucagon Receptor, Metabolic Research |
Retatrutide is a synthetic tri-agonist peptide investigated for its simultaneous interaction with GLP-1, GIP, and glucagon receptors. Preclinical research has focused on its effects on metabolic regulation and energy homeostasis pathways.
RESEARCH FOCUS AREAS:
- Multi-receptor agonist signalling studies
- Metabolic pathway regulation research
- Endocrine receptor interaction investigation
Retatrutide Amino Acid Sequence
Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Ala-Leu-Asp-Lys-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser (Lys20 carries a C20 fatty-diacid modification; tri-agonist analogue)
Certificate of Analysis
Every Imperial Peptides product is accompanied by a Certificate of Analysis (COA) confirming identity, purity (≥99%), and potency. Our COA documentation is generated by accredited third-party laboratories.